177 related articles for article (PubMed ID: 22285953)
1. The roles of angiotensin II receptors in the portosystemic collaterals of portal hypertensive and cirrhotic rats.
Huang HC; Chang CC; Wang SS; Lee FY; Teng TH; Lee JY; Lin HC; Chuang CL; Lee SD
J Vasc Res; 2012; 49(2):160-8. PubMed ID: 22285953
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
4. Effects of norepinephrine and acetylcholine on portal-systemic collaterals of common bile duct-ligated cirrhotic rat.
Chan CC; Chang CC; Huang HC; Wang SS; Lee FY; Chang FY; Lin HC; Tai CC; Lee SD
J Gastroenterol Hepatol; 2005 Dec; 20(12):1867-72. PubMed ID: 16336446
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
[TBL] [Abstract][Full Text] [Related]
6. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
8. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin.
Chan CC; Lee FY; Wang SS; Chang FY; Lin HC; Chu CJ; Tai CC; Lai IN; Lee SD
Hepatology; 1999 Sep; 30(3):630-5. PubMed ID: 10462367
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats.
Hsu SJ; Wang SS; Hsin IF; Huang HC; Lee FY; Lee JY; Lin HC; Chuang CL; Lee SD
Scand J Gastroenterol; 2013 Jul; 48(7):831-8. PubMed ID: 23672611
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren reduces portal pressure in portal hypertensive rats.
Chang CC; Lee WS; Huang HC; Lee FY; Wang SS; Lin HC; Nong JY; Lee SD
Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Khoo HE
Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
[TBL] [Abstract][Full Text] [Related]
12. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
13. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
Lee JY; Huo TI; Huang HC; Lee FY; Lin HC; Chuang CL; Chang CC; Wang SS; Lee SD
Clin Sci (Lond); 2011 Dec; 121(12):545-54. PubMed ID: 21736560
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
15. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Chu CJ; Chen CT; Huang HC; Lee SD
Hepatology; 2001 Apr; 33(4):816-20. PubMed ID: 11283844
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Lee FY; Liu RS; Chang FY; Lee SD
J Hepatol; 2002 May; 36(5):600-6. PubMed ID: 11983442
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
19. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
20. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
